MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.05, $0.03 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69.9 million versus the consensus estimate of $71.13 million.

GUIDANCE:

MiMedx Group sees FY2017 EPS of $0.31-$0.33, versus the consensus of $0.32. MiMedx Group sees FY2017 revenue of $302-307 million, versus the consensus of $304.8 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.